BMC cancerHumansComplement Factor HNeoplasmsBiomarkersTumor
Comprehensive cancer analysis reveals CFH as an immune-related and prognostic marker.
Xingguo Zheng, Chen Lv, Xiaoju Guo
Published: 202510.1186/s12885-025-15491-0
Abstract
BACKGROUND: Complement Factor H (CFH) has been reported as an indispensable role in innate and adaptive immunity. Despite increasing interest in CFH, its clinicopathological implications and immunological mechanisms across different cancers remain un…
Preview only. Read the full abstract at the source